Table 1

Clinical characteristics of SN-APS patients (n = 29)

CharacteristicsPatients
Vascular thrombosis 17 (58.6) 
    Venous thrombosis 11 (37.9) 
    Arterial thrombosis 7 (24.1) 
    Recurrent thrombosis 6 (20.7) 
Pregnancy morbidity 16 (55.2) 
    Normal fetus deaths 8 (27.6) 
    Premature births 5 (17.2) 
    Spontaneous abortions 8 (27.6) 
Vascular thrombosis and pregnancy morbidity  
    Noncriteria APS features 5 (17.2) 
        Livedo reticularis 18 (62.l) 
        Cognitive dysfunctions 13 (44.8) 
        Migraine 8 (27.6) 
        Seizures 2 (6.9) 
Brain MRI scan abnormalities  
    Thrombotic risk factors 8/19 (42.1) 
        Hypercholesterolemia 8 (27.6) 
        Smoking 8 (27.6) 
        Hypertension 6 (20.7) 
        OC/HRT 3 (10.3) 
        Diabetes mellitus 1 (3.4) 
CharacteristicsPatients
Vascular thrombosis 17 (58.6) 
    Venous thrombosis 11 (37.9) 
    Arterial thrombosis 7 (24.1) 
    Recurrent thrombosis 6 (20.7) 
Pregnancy morbidity 16 (55.2) 
    Normal fetus deaths 8 (27.6) 
    Premature births 5 (17.2) 
    Spontaneous abortions 8 (27.6) 
Vascular thrombosis and pregnancy morbidity  
    Noncriteria APS features 5 (17.2) 
        Livedo reticularis 18 (62.l) 
        Cognitive dysfunctions 13 (44.8) 
        Migraine 8 (27.6) 
        Seizures 2 (6.9) 
Brain MRI scan abnormalities  
    Thrombotic risk factors 8/19 (42.1) 
        Hypercholesterolemia 8 (27.6) 
        Smoking 8 (27.6) 
        Hypertension 6 (20.7) 
        OC/HRT 3 (10.3) 
        Diabetes mellitus 1 (3.4) 

Values are n (%).

APS indicates antiphospholipid syndrome; MRI, magnetic resonance imaging; OC/HRT, oral contraceptives/hormone-replacement therapy; and SN-APS, seronegative antiphospholipid syndrome.

Close Modal

or Create an Account

Close Modal
Close Modal